US9586381B1 - Metal plated object with biocidal properties - Google Patents
Metal plated object with biocidal properties Download PDFInfo
- Publication number
- US9586381B1 US9586381B1 US14/522,165 US201414522165A US9586381B1 US 9586381 B1 US9586381 B1 US 9586381B1 US 201414522165 A US201414522165 A US 201414522165A US 9586381 B1 US9586381 B1 US 9586381B1
- Authority
- US
- United States
- Prior art keywords
- plating
- plating layer
- metal
- metal plating
- copper
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
- 239000002184 metal Substances 0.000 title claims description 64
- 229910052751 metal Inorganic materials 0.000 title claims description 64
- 230000003115 biocidal effect Effects 0.000 title abstract description 23
- 238000007747 plating Methods 0.000 claims abstract description 164
- 229910052802 copper Inorganic materials 0.000 claims abstract description 35
- 239000010949 copper Substances 0.000 claims abstract description 35
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 34
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims abstract description 24
- 229910052718 tin Inorganic materials 0.000 claims abstract description 24
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 20
- 239000011701 zinc Substances 0.000 claims abstract description 20
- 230000000399 orthopedic effect Effects 0.000 claims description 15
- 230000005661 hydrophobic surface Effects 0.000 claims description 14
- 239000002335 surface treatment layer Substances 0.000 claims description 14
- 244000005700 microbiome Species 0.000 claims description 11
- 230000005540 biological transmission Effects 0.000 claims description 8
- 230000005660 hydrophilic surface Effects 0.000 claims description 8
- 239000007943 implant Substances 0.000 claims description 6
- 230000002401 inhibitory effect Effects 0.000 claims description 4
- 239000000463 material Substances 0.000 abstract description 18
- 238000000034 method Methods 0.000 abstract description 9
- 238000002360 preparation method Methods 0.000 abstract description 5
- 238000000151 deposition Methods 0.000 abstract 1
- 239000010410 layer Substances 0.000 description 96
- 239000011135 tin Substances 0.000 description 22
- 208000015181 infectious disease Diseases 0.000 description 16
- 241000894006 Bacteria Species 0.000 description 13
- 238000012360 testing method Methods 0.000 description 12
- 230000007423 decrease Effects 0.000 description 11
- 238000009428 plumbing Methods 0.000 description 10
- 238000012545 processing Methods 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- 230000008901 benefit Effects 0.000 description 7
- 230000002209 hydrophobic effect Effects 0.000 description 7
- 238000004381 surface treatment Methods 0.000 description 7
- 229910045601 alloy Inorganic materials 0.000 description 6
- 239000000956 alloy Substances 0.000 description 6
- 230000000845 anti-microbial effect Effects 0.000 description 6
- 244000052616 bacterial pathogen Species 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- KPYSYYIEGFHWSV-UHFFFAOYSA-N Baclofen Chemical compound OC(=O)CC(CN)C1=CC=C(Cl)C=C1 KPYSYYIEGFHWSV-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 5
- 229960000794 baclofen Drugs 0.000 description 5
- 238000011109 contamination Methods 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 238000012876 topography Methods 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 4
- 238000000502 dialysis Methods 0.000 description 4
- 231100000518 lethal Toxicity 0.000 description 4
- 230000001665 lethal effect Effects 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 3
- 230000007797 corrosion Effects 0.000 description 3
- 238000005260 corrosion Methods 0.000 description 3
- 239000000645 desinfectant Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000007769 metal material Substances 0.000 description 3
- 238000011176 pooling Methods 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 229910001369 Brass Inorganic materials 0.000 description 2
- 206010041925 Staphylococcal infections Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 239000010951 brass Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 2
- 238000001000 micrograph Methods 0.000 description 2
- 239000002110 nanocone Substances 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 206010039722 scoliosis Diseases 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 241001163841 Albugo ipomoeae-panduratae Species 0.000 description 1
- 108020000946 Bacterial DNA Proteins 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- 208000008238 Muscle Spasticity Diseases 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- -1 alkane thiol Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 206010008129 cerebral palsy Diseases 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 238000009713 electroplating Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000003906 hydrocephalus Diseases 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000003116 impacting effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 208000018198 spasticity Diseases 0.000 description 1
- 238000011272 standard treatment Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000012956 testing procedure Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- YUKQRDCYNOVPGJ-UHFFFAOYSA-N thioacetamide Chemical compound CC(N)=S YUKQRDCYNOVPGJ-UHFFFAOYSA-N 0.000 description 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B15/00—Layered products comprising a layer of metal
- B32B15/01—Layered products comprising a layer of metal all layers being exclusively metallic
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/358—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3598—Apparatus for preserving using solids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/10—Inorganic materials
- A61L29/106—Inorganic materials other than carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/082—Inorganic materials
- A61L31/088—Other specific inorganic materials not covered by A61L31/084 or A61L31/086
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C30/00—Alloys containing less than 50% by weight of each constituent
- C22C30/02—Alloys containing less than 50% by weight of each constituent containing copper
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C30/00—Alloys containing less than 50% by weight of each constituent
- C22C30/04—Alloys containing less than 50% by weight of each constituent containing tin or lead
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C30/00—Alloys containing less than 50% by weight of each constituent
- C22C30/06—Alloys containing less than 50% by weight of each constituent containing zinc
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C9/00—Alloys based on copper
- C22C9/02—Alloys based on copper with tin as the next major constituent
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C28/00—Coating for obtaining at least two superposed coatings either by methods not provided for in a single one of groups C23C2/00 - C23C26/00 or by combinations of methods provided for in subclasses C23C and C25C or C25D
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25D—PROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
- C25D3/00—Electroplating: Baths therefor
- C25D3/02—Electroplating: Baths therefor from solutions
- C25D3/56—Electroplating: Baths therefor from solutions of alloys
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25D—PROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
- C25D3/00—Electroplating: Baths therefor
- C25D3/02—Electroplating: Baths therefor from solutions
- C25D3/56—Electroplating: Baths therefor from solutions of alloys
- C25D3/58—Electroplating: Baths therefor from solutions of alloys containing more than 50% by weight of copper
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25D—PROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
- C25D3/00—Electroplating: Baths therefor
- C25D3/02—Electroplating: Baths therefor from solutions
- C25D3/56—Electroplating: Baths therefor from solutions of alloys
- C25D3/60—Electroplating: Baths therefor from solutions of alloys containing more than 50% by weight of tin
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25D—PROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
- C25D5/00—Electroplating characterised by the process; Pretreatment or after-treatment of workpieces
- C25D5/16—Electroplating with layers of varying thickness
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25D—PROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
- C25D5/00—Electroplating characterised by the process; Pretreatment or after-treatment of workpieces
- C25D5/48—After-treatment of electroplated surfaces
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25D—PROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
- C25D5/00—Electroplating characterised by the process; Pretreatment or after-treatment of workpieces
- C25D5/60—Electroplating characterised by the structure or texture of the layers
- C25D5/605—Surface topography of the layers, e.g. rough, dendritic or nodular layers
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25D—PROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
- C25D5/00—Electroplating characterised by the process; Pretreatment or after-treatment of workpieces
- C25D5/627—Electroplating characterised by the visual appearance of the layers, e.g. colour, brightness or mat appearance
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/02—Methods for coating medical devices
Definitions
- the present invention relates to metal plating and, more specifically, to metal plating objects to provide them with biocidal qualities.
- Nosocomial infections or “hospital-acquired infections” are one of the most lethal killers of hospital patients. In the United States alone, it is estimated that 1 in 9 patients (2 million patients per year) are infected by some form of potentially lethal germs or bacteria during their treatment and stay. Unfortunately, it is believed that 90,000 to 100,000 people a year die due to these infections or complications from infections.
- bacteria and other harmful microbes are resident on surfaces that are handled, introduced into a body or otherwise contacted in a manner that allows for the transfer of the microbes and resulting infection of a person or animal. While hospitals and other healthcare facilities present a concern with regard to such surfaces, other facilities, such as food handling facilities, may also present similar concerns.
- the present invention provides a metal plating with biocidal properties that can be used to inhibit infections.
- Pathogenic enteric germs and bacteria must have a certain type of environment to exist long enough to be transferred from one location to another. These bacteria, such as salmonellae, hepatitis, staphylococci, e. coli , etc., can be transferred in many different ways and can survive on many different types of surfaces for extended periods of time. The most significant mode of transfer is via contaminated hands, which come in contact with hardware parts such as door handles, faucets, sinks, medical equipment, fittings, furniture and many other types of hardware. If the conditions are suitable for the survival and growth of bacteria, the bacteria can be easily transmitted by contact with such hardware. In an environment where there are a large number of sick people whose immune systems are weakened, this provides an opportunity for the transmission of these potentially lethal bacteria and germs. Medical staff moving from patient to patient, medical procedures that bypass the body's natural protective barriers, and poor sanitation regarding uniforms, equipment sterilization and other preventive measures can compound the situation.
- the plating material has anti-microbial properties and has the potential to limit the growth and/or kill bacteria and germs that come into contact with it.
- the plating material is an alloy which includes copper, tin and zinc. Both copper and tin have germicidal properties. Copper has even been shown to be effective against methicillin-resistant staphylococcus aureus (“MRSA”) which is one of the more lethal strains of antibiotic resistant bacteria in existence today.
- MRSA methicillin-resistant staphylococcus aureus
- the copper containing alloy of the present application is resistant to oxidation.
- the disclosed alloy can generally withstand the use of cleaners, disinfectants and other solutions used to “sterilize” surfaces.
- the alloy can also be used to provide a uniform and bright surface and may have an appearance similar to nickel or stainless steel.
- the plating material includes approximately 55% copper (plus or minus 10%), 35% tin (plus or minus 10%) and 10% zinc (plus or minus 5%) by weight. In another embodiment, the plating material includes approximately 45% copper, 45% tin and 10% zinc (by weight).
- a surface treatment which includes a surfactant (1-5% by weight) and/or ethanol (0.1-10% by weight) may also be used with the plating layer.
- the invention comprises, in one form thereof, a device for inhibiting the transmission of microorganisms which includes a metal object adapted for use in an environment where the transmission of microorganisms is undesirable and a metal plating disposed on the metal object and forming at least a portion of the exterior surface of the object.
- the metal plating includes (by weight): copper within a range of about 45% to about 65%; tin within a range of about 25% to about 45%; and zinc within a range of about 5% to about 15%.
- the device is adapted to be implanted in a living organism.
- the device may be an orthopedic implant such as an orthopedic rod.
- the device might alternatively take the form of at least a portion of a stent, a catheter, a shunt or a baclofen pump.
- the device might be orthopedic hardware adapted for use either in an implanted condition or external to the patient.
- the device may be a part of a plumbing system, a piece of medical equipment, or food processing system. In some embodiments the device is a door handle.
- a hydrophobic surface treatment layer may advantageously be provided on the metal plating. In other applications, it may be advantageous to provide a hydrophilic treatment layer on the metal plating.
- the invention comprises, in another form thereof, a method of inhibiting the transmission of microorganisms in a food processing or medical care facility.
- the method includes providing a metal object for use within the facility; forming a metal plating on the metal object wherein the metal plating comprises (by weight): copper within a range of about 45% to about 65%; tin within a range of about 25% to about 45%; and zinc within a range of about 5% to about 15%.
- the metal plating includes no more than approximately 55% copper. In still other embodiments, the metal plating comprises copper within a range of about 45% to about 50%; tin within a range of about 40% to about 45%; and zinc within a range of about 5% to about 10%. For example the metal plating may include approximately 45% copper, approximately 45% tin and approximately 10% zinc. (Unless explicitly stated otherwise, all percentages of the metals comprising the plating layer used herein are by weight.)
- the finished surface of the metal plating is mechanically unprocessed.
- the exterior surface of the metal plating it can be advantageous in some applications to have the exterior surface of the metal plating be mechanically unprocessed when the surface treatment layer is formed thereon. Mechanically unprocessed surfaces will define small scale irregularities which are thought to enhance the biocidal properties of the surface.
- FIG. 1 is a schematic view of an object having a biocidal plating layer.
- FIG. 2 is a chart representing the light reflectance of the plating layer and that of several other surfaces.
- FIG. 3 is a schematic depiction of wear resistance testing procedure.
- FIG. 4A is a chart depicting the results of a wear resistance test.
- FIG. 4B is a chart depicting the surface profile of a copper surface having a wear track.
- FIG. 4C is a chart depicting the surface profile of a plated surface having a wear track.
- FIG. 4D is a chart depicting another surface profile of a plated surface having a wear track.
- FIG. 5 is a chart depicting how current density can impact the composition of the plating layer.
- FIG. 6 is a chart depicting how various parameters impact the composition of the plating layer.
- FIG. 7 is a chart depicting how various parameters impact the color of the plating layer.
- FIG. 8A is a schematic depiction of beaded water on a hydrophobic surface.
- FIG. 8B is a schematic depiction of water on a hydrophilic surface.
- FIG. 9 is a schematic depiction of a surface having nano-cones to provide a hydrophobic surface.
- FIG. 10 is a schematic depiction of a stent.
- FIG. 11 is a schematic depiction of a catheter and insertion needle.
- FIG. 12 is a schematic depiction of a shunt.
- FIG. 13 is a schematic depiction of an orthopedic rod.
- FIG. 14 is a schematic depiction of an orthopedic screw.
- FIG. 15 is a schematic depiction of an orthopedic reconstruction plate.
- FIG. 16 is a schematic depiction of an orthopedic external fixator.
- FIG. 17 is a schematic depiction of medical equipment.
- FIG. 18 is a schematic depiction of plumbing.
- FIG. 19 is a schematic depiction of a faucet and sink.
- FIG. 20 is a schematic depiction of a door handle.
- FIG. 21 is a schematic depiction of a baclofen pump.
- FIG. 22 is a schematic depiction of an implantable dialysis port.
- FIG. 23 is a schematic depiction of a food handling storage vessel.
- FIG. 24 is a schematic depiction of a food handling process line.
- FIG. 25 is a scanning electron microscope image showing the surface topography of a plating layer.
- FIG. 26 is another scanning electron microscope image showing the surface topography of a plating layer.
- a plated object 18 having a plating layer 20 deposited on a metal substrate 22 wherein plating layer 20 has biocidal properties is schematically depicted in FIG. 1 .
- the plating layer may have a composition (by weight) that is approximately 55% copper (plus or minus 10%), 35% tin (plus or minus 10%) and 10% zinc (plus or minus 5%).
- the plating layer may have a composition (by weight) wherein the amount of copper is within a range of about 45% to about 50%; tin is within a range of about 40% to about 45%; and zinc is within a range of about 5% to about 10%.
- the plating layer is 45% copper, 45% tin and 10% zinc.
- a surface treatment which includes a surfactant (1-5% by weight) and/or ethanol (0.1-10% by weight) may also be used with the plating layer.
- the disclosed plating layer has several other advantageous properties.
- the plating layer has an aesthetically pleasing surface similar in appearance to nickel or stainless steel and provides a uniform and bright surface.
- the plated surface displayed a reflectance of approximate 65% at a wavelength ( ⁇ ) of 400 nm. As the wavelength was increased, the reflectance also increased reaching a reflectance of slightly greater than 70% at a wavelength ( ⁇ ) of 700 nm.
- FIG. 2 is a chart representing the results of the reflectance test.
- the plating layer unlike copper, is resistant to oxidation and therefore does not easily tarnish and has good resistance to corrosion caused by hand perspiration. These properties make the plating layer well suited for use on handles and other objects that are frequently handled by users.
- the corrosion resistance of the plating layer allows it to be subjected to cleaners, disinfectants and similar sterilization solutions that are typically used in food preparation and medical care facilities where the transfer of microorganisms presents dangers.
- FIGS. 3 and 4A concern the wear resistance of the plating layer.
- FIG. 3 schematically depicts how a sliding wear test is performed on plated object 18 .
- a layer of plating material 20 is formed on metal substrate 24 which takes the form of a copper disk.
- a spherical rider 26 having a diameter of 4 mm takes the form of copper sphere with a plating layer formed thereon that is the same as plating layer 20 formed on disk 24 .
- a 100 g load is applied to rider 26 in a direction perpendicular to plating layer 20 formed on disk 24 as represented by arrow 28 .
- Rider 26 is subjected to reciprocal motion at a frequency of 0.5 Hz and an amplitude of 14 mm for 1000 cycles as represented by arrows 30 .
- FIG. 4 is a chart representing the results of the test. As can be seen in FIG. 4A , the frictional coefficient rises from an initial value of approximately 0.2 to a value of approximately 0.8 after roughly 200 cycles. The value of the frictional coefficient varies about 0.8 during the interval between 200 and 1000 cycles.
- FIGS. 4B-4D present charts showing three examples of surface profiles resulting from subjecting surfaces to a wear test as described above with reference to FIG. 3 .
- FIG. 4B presents the surface profile of a copper surface which developed a wear track having a depth of approximately 30 micrometers.
- FIG. 4C presents the surface of a first example of plating layer 20 which developed a wear track with a depth of approximately 3 micrometers and
- FIG. 4D presents the surface of a second example of plating layer 20 which developed a wear track with a depth of approximately 4 micrometers.
- plating 20 provides a wear resistant surface.
- the exemplary embodiment of plating layer 20 has a hardness (Vickers) of approximately 450-500 Hv 0.05 . It has a specific gravity (g/cm 3 ) of approximately 8.2-8.5.
- the plating layer is electrically conductive and non-magnetic.
- Plating layer 20 also displayed excellent corrosion resistance as will be recognized by those having ordinary skill in the art upon review of the following test results for plating layer 20 :
- plating layer 20 also possesses biocidal properties and can inhibit the growth and potentially kill many forms of bacteria, fungus, germs and other microorganisms.
- a plating layer 20 having a thickness of approximately 0.000050 inches (0.00013 cm) applied to a brass panel provided positive results within an hour when exposed to staphylococcus aureus germs. Additional testing has shown that a plating 20 was able to achieve antimicrobial functionality against S. aureus (MRSA) at an 99.99% reduction in just 6 hours of exposure.
- MRSA S. aureus
- a plating layer 20 demonstrated anti-microbial functionality against E.
- plating layer 20 was able to achieve antimicrobial functionality against E. coli (CRE) at greater than 99.9998% reduction in 24 hours.
- CRE E. coli
- Other testing involving plating layer 20 has also demonstrated a 90% reduction in spore colonies including effectiveness against a disinfectant resistant endospore. Assuming a patient exposure of 2.5 grams of plating layer 20 , this would be below levels of toxicological concern. With regard to MEM cytotoxicity, plating layer 20 is not cytotoxic.
- One embodiment of the bath makeup that may be used is CuCN 72 g/liter; Sn 18 g/liter; ZnCN 22 g/liter; KCN 300 g/liter; KOH 20 g/liter and an organic brightener and organic wetter wherein the organic brightener and organic wetter are provided in a ratio of 0.4 liter organic brightener to 1.0 liter of organic wetter.
- the operating parameters of the bath are advantageously maintained within the following ranges: CuCN 12.5-18 g/liter; Sn 14-28 g/liter; ZnCN 3.0-6.0 g/liter; CN 50-70 g/liter; and KOH 15-25 g/liter.
- the bath is not very sensitive to metallic contamination. Rinsing the pieces well before plating, however, facilitates good quality work and helps prevent contamination of the bath. Ni ( ⁇ 15 ppm) and Cr are potentially harmful contaminants and can be introduced by the use of stainless steel anodes. As a result, the use of insoluble anodes will generally provide more desirable results.
- FIG. 6 A chart depicting how several significant parameters can impact the composition of the plating layer is provided in FIG. 6 .
- increasing the concentration of KOH in the bath increases the percentage of copper and zinc in the plating layer while decreasing the percentage of tin.
- the decrease of KOH has the opposite effect.
- Increasing the temperature increases the amount of tin in the plating layer while decreasing that of copper and zinc. Decreasing the temperature has the opposite effect.
- Increasing the concentration of KCN in the bath decreases the percentage of copper and increases the percentage of tin while not impacting the percentage of zinc in the plating layer.
- Decreasing the concentration of KCN increases the percentage of copper, decreases that of tin and has no impact on the amount of zinc.
- Increasing the current density increases the percentage of copper in the plating layer, decreases the percentage of tin and does not alter the percentage of zinc. Decreasing the current density decreases the percentage of copper, increases the percentage of tin and does not impact that of zinc.
- FIG. 7 A chart depicting how various parameters impact the color of the plating layer is provided in FIG. 7 .
- increasing the percentage of copper in the plating layer decreases the grey color and increases the yellow color of the plating layer.
- Increasing the percentage of tin in the alloy forming the plating layer increases the grey and decreases the yellow color of the plating layer. Consequently, increasing the concentration of KOH in the bath will decrease the grey and increase the yellow color of the resulting plating layer.
- Increasing the concentration of KCN will increase the grey and decrease the yellow of the plating layer.
- Increasing the temperature of the bath will increase the grey and decrease the yellow color of the resulting plating layer while increasing the current density will decrease the grey and increase the yellow color of the plating layer deposited on the piece.
- FIG. 8 schematically depicts water beads 34 on a plated object having a surface which has been treated to provide it with hydrophobic properties.
- One particularly effective manner of providing a hydrophobic surface is the use of self-assembling molecules (SAMs).
- FIG. 9 schematically depicts how SAMs can be used to form nano-cones 36 having hydrophobic properties.
- the hydrophobic surface treatment layer may be formed using any suitable materials and methods.
- a variety of materials are commercially available for forming hydrophobic surfaces.
- One example of such a surface treatment that may be used with metal plating 20 is formed using Bronzex® Nano 1000W a product commercially available from Enthone, a subsidiary of Cookson Group PLC and having a place of business in Surrey, England.
- This material includes 1-5% (by weight) of a surfactant/alkane thiol mixture and 0.1-1.0% (by weight) of a proprietary alcohol.
- the application of the hydrophobic layer includes immersing the plated layer 20 in a bath of the material at 120° F. to 125° F. for 10 minutes with vigorous mechanical agitation. This is followed by two deionized water rinses for 2 to 3 minutes at ambient temperature. Then a hot (150° F. to 160°) deionized water rinse for 1 to 2 minutes and then a centrifugal dry for 10 minutes.
- Plating layer 20 may alternatively have a hydrophilic surface treatment layer 33 which has been treated to provide it with hydrophilic properties.
- the plating layer 20 may be immersed in suitable hydrophilic material bath, rinsed and dried.
- the intended use of the plated object will determine whether it is more advantageous for the surface to be hydrophobic or hydrophilic.
- the schematic depictions of surface treatment layers 32 , 33 indicate that such layers completely cover plating layer 20 . This is a graphical oversimplification, when provided with a hydrophobic or hydrophilic surface treatment layer 32 , 33 , the surface treatment layer is a thin layer that does not foreclose all interaction between the underlying plating layer 20 and microbes in the external environment.
- plating layer 20 there may be some surface area of plating layer 20 that is not covered by the surface treatment layer, e.g., area between the cones schematically depicted in FIG. 9 .
- metal plating 20 destroys bacteria and other microbes by coaxing the organism to donate electrons to metal plating thereby resulting in the production of free radicals within the cell whereafter the free radicals inflict damage to bacterial DNA and cell proteins.
- This mechanism merely requires that the microbes and metal plating be relatively positioned whereby the metal plating 20 can attract electrons from the microbes. It is believed that this mechanism can be effective with a thin hydrophobic or hydrophilic surface treatment layer disposed on the external surface of metal plating 20 .
- FIGS. 25 and 26 are images obtained with a scanning electron microscope of a plating layer 20 showing small scale irregularities.
- FIG. 25 is an image that was originally at 1000:1 scale while FIG. 26 was originally 2000:1 scale.
- small scale irregularities may enhance the anti-microbial effects of the surface when the irregularities are on a scale that is smaller than the organism of concern.
- the presence of such small scale irregularities in the surface can deny bacterium and other microbes a “flat” surface to land and instead require the organism to attach to limited and separated areas of attachment (e.g, the top of adjacent ridges). This is thought to cause mechanical stress on the organism and thereby discourage the organism from settling on and colonizing the surface.
- plating layer 20 hydrophilic (readily attracting water)
- the surface will have a propensity to dry quicker, rather than “pooling” the liquid on certain areas of the surface.
- the surface is likely to dry unevenly with the pools of liquid drying more slowly and thereby result in the continued loading of microbes in the surfaces areas subject to the pooling of the liquid.
- treating the external surface of plating 20 to render it hydrophilic can promote the rapid drying of the surface and thereby enhance its antimicrobial efficacy.
- a hydrophobic surface treatment for plated objects that are intended to be at least partially implanted in a living organism, e.g., a human being, for either a short or long duration of time, it may be desirable to provide such objects with a hydrophobic surface treatment.
- the hydrophobic properties of such a surface can affect the interaction between the surface and such bodily fluids as blood, mucous, saliva, urine, perspiration as well as other associated and potentially contaminated fluids and limit the adherence of such liquids to the surface and formation of biofilms thereon. It is also thought, although not yet demonstrated, that providing a plating 20 with hydrophobic properties on an implantable object could potentially act as an anticoagulant and help prevent clotting and strokes. It is also thought it may be useful in treating or preventing thrombosis. In this regard, it is noted that such a treatment on a stent 38 could provide particularly significant benefits.
- a plating layer 20 in a food preparation/handling facility or a medical care facility has the potential to inhibit the growth and transmission of potentially harmful microorganisms.
- a plating layer 20 could be applied to the handles used on the doors, plumbing fixtures and furniture in a medical care facility.
- plating layer 20 could be applied to not only the plumbing fixture handles but also the plumbing structure which is exposed but not generally touched by users.
- a plating layer 20 could also be applied to the knobs, switches and housings of medical equipment used in a medical care facility. It could also be applied to the knobs, switches and housing of non-medical equipment that is intended for use in a medical care facility.
- Beds and other support structures found in medical care facilities often include metallic members which could also benefit from being plated with plating layer 20 .
- Other metallic surfaces found in medical care facilities could also benefit by being provided with a biocidal plating layer 20 .
- many medical instruments and implanted objects that directly contact the medical care provider and/or the patient could also benefit by being provided with a plating layer 20 .
- the exposed metallic surfaces and tools used in the facility could be plated with a plating layer 20 to inhibit the growth and transmission of potentially harmful microorganisms.
- FIGS. 10-24 schematically depict a variety of objects that could be provided with a biocidal plating layer 20 to enhance the performance of the objects.
- FIGS. 10-12 all illustrate examples of medical applications wherein a plating layer 20 is applied to an object that is adapted to be implanted in a living organism such as a human being.
- FIG. 10 illustrates a stent 38 which having an outer plating layer 20 .
- FIG. 11 illustrates a catheter 40 and a catheter needle 42 .
- the metal components of the catheter 40 and catheter needle can beneficially have a plating layer 20 applied thereto.
- FIG. 12 illustrates a shunt 44 having a proximal catheter 46 , a distal catheter 48 and a valve assembly 50 .
- the metal components of such implantable devices may beneficially have a plating layer 20 applied thereto.
- a metallic component having a plating layer 20 instead of a component more commonly formed of plastic in such devices.
- a metallic component having a plating layer 20 instead of a component more commonly formed of plastic in such devices.
- the biocidal properties of plating 20 may justify the substitution of a metallic tube with plating 20 for a plastic tube in some catheters.
- ventriculo-peritoneal shunts are commonly used devices in pediatric patients for hydrocephalus or interventricular hemorrhages.
- the shunts 44 remain in place for prolonged periods, sometimes for life, and must be tapped periodically for a variety of reasons. A certain percentage of these patients develop an infection at the site where the shunts 44 interface with the cerebrospinal fluid. If the valve assembly 50 at the interface is plated with a layer of biocidal plating 20 this has the potential to reduce the incidence of infection.
- the test data presented above shows that the plating 20 has excellent bactericidal results with at least some of the organisms that may infect pediatric shunts.
- FIGS. 13-16 schematically illustrate examples of such orthopedic hardware having an external plating layer 20 .
- FIG. 13 depicts spinal rods 52 and pedicle screws 51
- FIG. 14 depicts a bone screw 54
- FIG. 15 depicts a reconstruction plate 56
- FIG. 16 depicts an external fixator 58 .
- Various other orthopedic hardware and instrumentation such as intramedullary rods could also have metal plating 20 applied thereto.
- FIG. 17 depicts a piece of medical equipment 60 that may take the form of a dialysis machine wherein many of the metal components of equipment 60 may have plating 20 applied thereto.
- housing 62 manual controls 60 , such as knobs and switches may all be metal components having an exterior surface formed by metal plating 20 .
- support cart 66 may have some or all of its metal parts plated with metal plating 20 .
- the various components of the plumbing system in a medical or food preparation facility may also have metal plating 20 applied thereto to reduce the risk of infection.
- This may include plumbing infrastructure components 68 that are not subject to handling by people on a regular basis. Examples of such plumbing infrastructure is depicted in FIG. 18 . It may also include plumbing components that do regularly come into contact with the hands of people within the facility such as those components depicted in FIG. 19 .
- Depicted in FIG. 19 is a sink 70 , faucet 72 and handles 74 . Faucet 72 and handles 74 are quite commonly manufactured out of a metal material and would benefit from having a layer of metal plating 20 .
- Sinks 70 may also be formed out of metal material and be provided with a layer of metal plating 20 to inhibit the transfer of microorganisms.
- door handles 76 are one piece of hardware that is subjected to a large amount of handling by persons within a facility and would benefit from the application of metal plating 20 .
- the application of a biocidal metal plating 20 to exposed hardware 78 such as the door handle faceplate depicted in FIG. 20 would also help reduce the transfer and growth of microorganisms even though such hardware may not be subject to extensive handling.
- FIG. 21 illustrates a baclofen pump 80 having a metal housing 82 with an outer layer formed by biocidal plating 20 .
- Baclofen pumps are used to administer baclofen in a controlled dose to help patients suffering from spasticity from certain diagnoses like cerebral palsy.
- the pumps are implanted under the skin in a pocket in the abdominal area. Sometimes the pocket site around the pump becomes infected, necessitating surgical removal and prolonged antibiotic therapy. If the pump casing is coated with a plating layer 20 , this could potentially reduce the incidence of infection in such patients.
- FIG. 22 illustrates another medical application for metal plating 20 .
- This exemplary embodiment takes the form of a dialysis port 84 having a metal port member 86 with a coating of plating 20 .
- a dialysis port 84 having a metal port member 86 with a coating of plating 20 .
- Adult dialysis patients are often fitted with a graft with an access port that is used to administer their hemodialysis treatment. Infection of these ports is quite common.
- the ports are typically made out of plastic materials. By making the ports 86 out of a metal material and plating the ports with metal plating 20 , it may be possible to obtain a reduction in infections at the port site.
- FIGS. 23 and 24 The use of plating 20 in a food processing facility is represented in FIGS. 23 and 24 .
- a storage vessel 88 is depicted. Both the inner and outer surfaces of vessel 88 may advantageously include a layer of plating 20 to potentially reduce the risk of contaminating the food being stored in the vessel and being processed in the facility.
- FIG. 24 schematically depicts a food processing line 90 having a dispensing station 92 , a conveyor system 94 and a weighing and packaging station 96 .
- the various metal components of these stations and systems may be advantageously coated with plating 20 . It is thought that such an application of plating 20 will reduce the potential for contamination of the food being processed.
- food processing facility may also be able to reduce the threat of contamination by applying a biocidal plating on metal fixtures throughout the facility in a manner similar to that discussed above with regard to medical care facilities.
- a biocidal plating on metal fixtures throughout the facility in a manner similar to that discussed above with regard to medical care facilities.
- plumbing system components could be plated with metal plating 20 as exemplified by FIGS. 18 and 19 .
- a hydrophilic surface treatment on plating layer 20 where the object is regularly cleaned and dried, e.g., daily, such as a table top on which food materials are handled or the housing of a piece of equipment.
- the object is regularly cleaned and dried, e.g., daily, such as a table top on which food materials are handled or the housing of a piece of equipment.
- the use of a hydrophobic surface treatment on plating layer 20 may be advantageous.
Abstract
Description
-
- artificial sweat (ISO 3160): <24 h
- thioacetamide: >24 h
- NSS: brass: 48 H to white rust, >122 H
- humid atmosphere (85° C.-85% RH): >72 Hrs
- thermal cycles: −50° C./+85° C., RH=70% for 10 days (1000 cycles): no discoloration
- tarnish resistance: no color change after 4 H exposure at 150° C.
Claims (8)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/522,165 US9586381B1 (en) | 2013-10-25 | 2014-10-23 | Metal plated object with biocidal properties |
US15/413,573 US20170128631A1 (en) | 2013-10-25 | 2017-01-24 | Metal plated object with biocidal properties |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361895644P | 2013-10-25 | 2013-10-25 | |
US14/522,165 US9586381B1 (en) | 2013-10-25 | 2014-10-23 | Metal plated object with biocidal properties |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/413,573 Division US20170128631A1 (en) | 2013-10-25 | 2017-01-24 | Metal plated object with biocidal properties |
Publications (1)
Publication Number | Publication Date |
---|---|
US9586381B1 true US9586381B1 (en) | 2017-03-07 |
Family
ID=58162178
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/522,165 Active 2035-01-09 US9586381B1 (en) | 2013-10-25 | 2014-10-23 | Metal plated object with biocidal properties |
US15/413,573 Abandoned US20170128631A1 (en) | 2013-10-25 | 2017-01-24 | Metal plated object with biocidal properties |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/413,573 Abandoned US20170128631A1 (en) | 2013-10-25 | 2017-01-24 | Metal plated object with biocidal properties |
Country Status (1)
Country | Link |
---|---|
US (2) | US9586381B1 (en) |
Citations (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2473886A (en) * | 1947-06-30 | 1949-06-21 | Westinghouse Electric Corp | Brazing alloy |
US4098610A (en) | 1977-05-23 | 1978-07-04 | Corning Glass Works | Biocidal glass additive for marine paints |
US4482596A (en) | 1980-09-15 | 1984-11-13 | Shipley Company Inc. | Electroless alloy plating |
US5042575A (en) | 1990-08-27 | 1991-08-27 | General Motors Corporation | Evaporator core having biocidal fixture |
US5441717A (en) | 1992-05-21 | 1995-08-15 | Toagosei Chemical Industry Co., Inc., Ltd. | Process for producing antimicrobial compounds |
US5494565A (en) * | 1993-01-27 | 1996-02-27 | Degussa Aktiengesellschaft | Method of producing workpieces of non-corrosion-resistant metals with wear-resistant coatings and articles |
US5681575A (en) | 1992-05-19 | 1997-10-28 | Westaim Technologies Inc. | Anti-microbial coating for medical devices |
US5972526A (en) * | 1995-12-07 | 1999-10-26 | Citizen Watch Co., Ltd. | Decorative member |
US6080490A (en) | 1990-12-24 | 2000-06-27 | Westaim Technologies Inc. | Actively sterile surfaces |
US6146702A (en) | 1995-06-06 | 2000-11-14 | Enthone-Omi, Inc. | Electroless nickel cobalt phosphorous composition and plating process |
US6190407B1 (en) | 1997-11-20 | 2001-02-20 | St. Jude Medical, Inc. | Medical article with adhered antimicrobial metal |
US6273875B1 (en) | 1998-08-17 | 2001-08-14 | Edwards Lifesciences Corporation | Medical devices having improved antimicrobial/antithrombogenic properties |
US6365220B1 (en) | 1997-11-03 | 2002-04-02 | Nucryst Pharmaceuticals Corp. | Process for production of actively sterile surfaces |
CN1412329A (en) * | 2001-10-10 | 2003-04-23 | 朱景明 | Arroy material suitable for making cutter |
US20030110600A1 (en) * | 2001-12-14 | 2003-06-19 | Ykk Corporation | Slide fastener and method of manufacturing attachment having constituent members |
US6780527B2 (en) * | 2000-06-27 | 2004-08-24 | Citizen Watch Co., Ltd. | Decorative article having white film and production method therefor |
US20050119743A1 (en) | 2002-04-16 | 2005-06-02 | Pickford Martin Edward L. | Metal implants |
US6938668B2 (en) | 2000-01-25 | 2005-09-06 | Scimed Life Systems, Inc. | Manufacturing medical devices by vapor deposition |
US20050202099A1 (en) | 2004-03-10 | 2005-09-15 | Globe Union Industrial Corp. | Anti-microbial sanitary ware and method for making the same |
US20050202100A1 (en) | 2004-03-11 | 2005-09-15 | Maria Dekkers Josephus H.C. | Biocidal compositions and methods of making thereof |
US20060246353A1 (en) * | 2005-04-29 | 2006-11-02 | Jingdong Guo | Alkaline cell anode casing |
US20070181221A1 (en) | 2004-03-13 | 2007-08-09 | Pickford Martin E L | Metal implants |
US7300673B2 (en) | 2003-05-16 | 2007-11-27 | Exciton Technologies Inc. | Deposition products, composite materials and processes for the production thereof |
US7427416B2 (en) | 2000-07-27 | 2008-09-23 | Nucryst Pharmaceuticals Corp. | Methods of treating conditions using metal-containing materials |
US20080317800A1 (en) | 2006-02-16 | 2008-12-25 | Djamschid Amirzadeh-Asl | Biocidal Composition |
US7510724B2 (en) | 1998-08-07 | 2009-03-31 | Leica Microsystems (Schweiz) Ag | Medical apparatus |
US7608581B2 (en) | 2004-06-16 | 2009-10-27 | Affinergy, Inc. | Biofunctional, antimicrobial coatings for medical devices |
US7650848B2 (en) | 2004-02-17 | 2010-01-26 | University Of Florida Research Foundation, Inc. | Surface topographies for non-toxic bioadhesion control |
US7745509B2 (en) | 2003-12-05 | 2010-06-29 | 3M Innovative Properties Company | Polymer compositions with bioactive agent, medical articles, and methods |
US20100206733A1 (en) | 2007-10-03 | 2010-08-19 | Accentus Plc | Method of Manufacturing Metal with Biocidal Properties |
US7897266B2 (en) | 2007-02-09 | 2011-03-01 | Rovcal, Inc. | Personal grooming device having a tarnish resistant, hypoallergenic and/or antimicrobial silver alloy coating thereon |
US20110256356A1 (en) * | 2007-12-20 | 2011-10-20 | Integran Technologies, Inc. | Metallic Structures with Variable Properties |
US8124169B2 (en) | 2005-12-14 | 2012-02-28 | 3M Innovative Properties Company | Antimicrobial coating system |
US20120171406A1 (en) * | 2009-09-08 | 2012-07-05 | Mitsui Chemicals, Inc. | Antimicrobial raw material and method for manufacturing the same, and antimicrobial material |
US8309117B2 (en) | 2002-12-19 | 2012-11-13 | Novartis, Ag | Method for making medical devices having antimicrobial coatings thereon |
US20120321686A1 (en) | 2009-12-24 | 2012-12-20 | Eth Zurich | Antifungal Material |
US20130004585A1 (en) | 2009-12-11 | 2013-01-03 | Difusion Technologies, Inc. | Method Of Manufacturing Antimicrobial Implants Of Polyetheretherketone |
US20130014671A1 (en) | 2011-07-11 | 2013-01-17 | Yu-Hong Tzeng | Antimicrobial dental material |
US20130216169A1 (en) * | 2010-04-15 | 2013-08-22 | Miba Gleitlager Gmbh | Multi-layer plain bearing having an anti-fretting layer |
WO2013155618A1 (en) | 2012-04-20 | 2013-10-24 | 9163-0384 Québec Inc. | Anodized metal product with antimicrobial properties and method for producing the same |
WO2013159216A1 (en) | 2012-04-24 | 2013-10-31 | Aereus Technologies Inc. | Coatings, coated surfaces, and methods for production thereof |
US8691397B2 (en) | 2009-06-02 | 2014-04-08 | Integran Technologies, Inc. | Biocidal metallic layers comprising cobalt |
US8708978B2 (en) | 2005-03-17 | 2014-04-29 | Impactcare Aps | Article to be inserted in a body cavity having biologically inhibiting surfaces and use and preparation of the article |
US20140141263A1 (en) | 2011-06-21 | 2014-05-22 | Akzo Nobel Coatings International B.V. | Biocidal foul release coating systems |
US20140147332A1 (en) | 2012-10-26 | 2014-05-29 | Sloan Valve Company | White Antimicrobial Copper Alloy |
US8778408B2 (en) | 2011-02-18 | 2014-07-15 | Mitsui Chemicals, Inc. | Antimicrobial substance, method for producing same, and antimicrobial material |
-
2014
- 2014-10-23 US US14/522,165 patent/US9586381B1/en active Active
-
2017
- 2017-01-24 US US15/413,573 patent/US20170128631A1/en not_active Abandoned
Patent Citations (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2473886A (en) * | 1947-06-30 | 1949-06-21 | Westinghouse Electric Corp | Brazing alloy |
US4098610A (en) | 1977-05-23 | 1978-07-04 | Corning Glass Works | Biocidal glass additive for marine paints |
US4482596A (en) | 1980-09-15 | 1984-11-13 | Shipley Company Inc. | Electroless alloy plating |
US5042575A (en) | 1990-08-27 | 1991-08-27 | General Motors Corporation | Evaporator core having biocidal fixture |
US6080490A (en) | 1990-12-24 | 2000-06-27 | Westaim Technologies Inc. | Actively sterile surfaces |
US5681575A (en) | 1992-05-19 | 1997-10-28 | Westaim Technologies Inc. | Anti-microbial coating for medical devices |
US5770255A (en) * | 1992-05-19 | 1998-06-23 | Westaim Technologies, Inc. | Anti-microbial coating for medical devices |
US5441717A (en) | 1992-05-21 | 1995-08-15 | Toagosei Chemical Industry Co., Inc., Ltd. | Process for producing antimicrobial compounds |
US5494565A (en) * | 1993-01-27 | 1996-02-27 | Degussa Aktiengesellschaft | Method of producing workpieces of non-corrosion-resistant metals with wear-resistant coatings and articles |
US6146702A (en) | 1995-06-06 | 2000-11-14 | Enthone-Omi, Inc. | Electroless nickel cobalt phosphorous composition and plating process |
US5972526A (en) * | 1995-12-07 | 1999-10-26 | Citizen Watch Co., Ltd. | Decorative member |
US6365220B1 (en) | 1997-11-03 | 2002-04-02 | Nucryst Pharmaceuticals Corp. | Process for production of actively sterile surfaces |
US6190407B1 (en) | 1997-11-20 | 2001-02-20 | St. Jude Medical, Inc. | Medical article with adhered antimicrobial metal |
US7510724B2 (en) | 1998-08-07 | 2009-03-31 | Leica Microsystems (Schweiz) Ag | Medical apparatus |
US6273875B1 (en) | 1998-08-17 | 2001-08-14 | Edwards Lifesciences Corporation | Medical devices having improved antimicrobial/antithrombogenic properties |
US6938668B2 (en) | 2000-01-25 | 2005-09-06 | Scimed Life Systems, Inc. | Manufacturing medical devices by vapor deposition |
US6780527B2 (en) * | 2000-06-27 | 2004-08-24 | Citizen Watch Co., Ltd. | Decorative article having white film and production method therefor |
US7427416B2 (en) | 2000-07-27 | 2008-09-23 | Nucryst Pharmaceuticals Corp. | Methods of treating conditions using metal-containing materials |
CN1412329A (en) * | 2001-10-10 | 2003-04-23 | 朱景明 | Arroy material suitable for making cutter |
US20030110600A1 (en) * | 2001-12-14 | 2003-06-19 | Ykk Corporation | Slide fastener and method of manufacturing attachment having constituent members |
US20050119743A1 (en) | 2002-04-16 | 2005-06-02 | Pickford Martin Edward L. | Metal implants |
US20100032309A1 (en) | 2002-04-16 | 2010-02-11 | Accentus Plc | Metal Implants |
US20100036501A1 (en) | 2002-04-16 | 2010-02-11 | Accentus Plc | Metal Implants |
US8309117B2 (en) | 2002-12-19 | 2012-11-13 | Novartis, Ag | Method for making medical devices having antimicrobial coatings thereon |
US7300673B2 (en) | 2003-05-16 | 2007-11-27 | Exciton Technologies Inc. | Deposition products, composite materials and processes for the production thereof |
US7998504B2 (en) | 2003-05-16 | 2011-08-16 | Exciton Technologies Inc. | Deposition products, composite materials and processes for the production thereof |
US7745509B2 (en) | 2003-12-05 | 2010-06-29 | 3M Innovative Properties Company | Polymer compositions with bioactive agent, medical articles, and methods |
US7650848B2 (en) | 2004-02-17 | 2010-01-26 | University Of Florida Research Foundation, Inc. | Surface topographies for non-toxic bioadhesion control |
US20060251730A1 (en) | 2004-03-10 | 2006-11-09 | Lo Wen L | Anti-microbial sanitary ware and method for making the same |
US20050202099A1 (en) | 2004-03-10 | 2005-09-15 | Globe Union Industrial Corp. | Anti-microbial sanitary ware and method for making the same |
US20050202100A1 (en) | 2004-03-11 | 2005-09-15 | Maria Dekkers Josephus H.C. | Biocidal compositions and methods of making thereof |
US20070181221A1 (en) | 2004-03-13 | 2007-08-09 | Pickford Martin E L | Metal implants |
US7608581B2 (en) | 2004-06-16 | 2009-10-27 | Affinergy, Inc. | Biofunctional, antimicrobial coatings for medical devices |
US8708978B2 (en) | 2005-03-17 | 2014-04-29 | Impactcare Aps | Article to be inserted in a body cavity having biologically inhibiting surfaces and use and preparation of the article |
US20060246353A1 (en) * | 2005-04-29 | 2006-11-02 | Jingdong Guo | Alkaline cell anode casing |
US8124169B2 (en) | 2005-12-14 | 2012-02-28 | 3M Innovative Properties Company | Antimicrobial coating system |
US20080317800A1 (en) | 2006-02-16 | 2008-12-25 | Djamschid Amirzadeh-Asl | Biocidal Composition |
US7897266B2 (en) | 2007-02-09 | 2011-03-01 | Rovcal, Inc. | Personal grooming device having a tarnish resistant, hypoallergenic and/or antimicrobial silver alloy coating thereon |
US20100206733A1 (en) | 2007-10-03 | 2010-08-19 | Accentus Plc | Method of Manufacturing Metal with Biocidal Properties |
US20110256356A1 (en) * | 2007-12-20 | 2011-10-20 | Integran Technologies, Inc. | Metallic Structures with Variable Properties |
US8691397B2 (en) | 2009-06-02 | 2014-04-08 | Integran Technologies, Inc. | Biocidal metallic layers comprising cobalt |
US20120171406A1 (en) * | 2009-09-08 | 2012-07-05 | Mitsui Chemicals, Inc. | Antimicrobial raw material and method for manufacturing the same, and antimicrobial material |
US20130004585A1 (en) | 2009-12-11 | 2013-01-03 | Difusion Technologies, Inc. | Method Of Manufacturing Antimicrobial Implants Of Polyetheretherketone |
US20120321686A1 (en) | 2009-12-24 | 2012-12-20 | Eth Zurich | Antifungal Material |
US20130216169A1 (en) * | 2010-04-15 | 2013-08-22 | Miba Gleitlager Gmbh | Multi-layer plain bearing having an anti-fretting layer |
US8778408B2 (en) | 2011-02-18 | 2014-07-15 | Mitsui Chemicals, Inc. | Antimicrobial substance, method for producing same, and antimicrobial material |
US20140141263A1 (en) | 2011-06-21 | 2014-05-22 | Akzo Nobel Coatings International B.V. | Biocidal foul release coating systems |
US20130014671A1 (en) | 2011-07-11 | 2013-01-17 | Yu-Hong Tzeng | Antimicrobial dental material |
WO2013155618A1 (en) | 2012-04-20 | 2013-10-24 | 9163-0384 Québec Inc. | Anodized metal product with antimicrobial properties and method for producing the same |
WO2013159216A1 (en) | 2012-04-24 | 2013-10-31 | Aereus Technologies Inc. | Coatings, coated surfaces, and methods for production thereof |
US20140147332A1 (en) | 2012-10-26 | 2014-05-29 | Sloan Valve Company | White Antimicrobial Copper Alloy |
Non-Patent Citations (8)
Title |
---|
Emergence of superhydrophobic behavior on vertically aligned nanocone arrays, D'Urso et al., Applied Physics Letters, 90, 044102 (2007). |
Evaluating the Feasibility of Reducing Surface Contamination in Healthcare Facilities with Micro-Pattern Films, May et al., CHICAACGO Presentation, 51st ICAAC, Sep. 17-20, 2011, Chicago, IL. |
Guide to Tri-MTM Plating, Electro-Spec, Inc., Franklin, Indiana, at least as early as Oct. 24, 2012 (4 pages). |
SAM's Technology (Self Assembled Molecules), Electro-Spec, Inc., Franklin, Indiana, at least as early as Oct. 24, 2012 (1 page). |
Serro et al., "A comparative study of titanium nitrides, TiN, TiNbN, TiCN, as coatings for biomedical applications", Jun. 2009, Surface & Coatings Technology, vol. 203, pp. 3701-3707. * |
Telecommunications Plating, Electro-Spec, Inc., Franklin, Indiana, at least as early as Oct. 24, 2012 (2 pages). |
Tri-M3TM (Tri-Alloy, Tri-Metal or White Bronze) Plating, Electro-Spec, Inc., Franklin, Indiana, at least as early as Oct. 24, 2012 (3 pages). |
Written Testimony of Jeffrey D. Smith President/CEO of Electro-Spec, Inc. and President of Steriplate, LLC submitted to the Subcommittee on Research and Technology Committee on Science, Space and Technology for the hearing entitled Technology for Patient Safety at Veterans Hospitals, U.S. House of Representatives, Washington, D.C., Jun. 26, 2014 (15 pages). |
Also Published As
Publication number | Publication date |
---|---|
US20170128631A1 (en) | 2017-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Von Eiff et al. | Infections associated with medical devices: pathogenesis, management and prophylaxis | |
Verran et al. | Factors affecting microbial adhesion to stainless steel and other materials used in medical devices | |
Weber et al. | Self-disinfecting surfaces: review of current methodologies and future prospects | |
Tenke et al. | European and Asian guidelines on management and prevention of catheter-associated urinary tract infections | |
US5709672A (en) | Silastic and polymer-based catheters with improved antimicrobial/antifungal properties | |
US4886505A (en) | Antimicrobial surfaces and inhibition of microorganism growth thereby | |
US6004438A (en) | Biofilm reduction sterilizer | |
Seddiki et al. | Evidence of antibacterial activity on titanium surfaces through nanotextures | |
Caldara et al. | Environmental, microbiological, and immunological features of bacterial biofilms associated with implanted medical devices | |
KR20140140600A (en) | A medical device having a surface comprising gallium oxide | |
JP2010527335A (en) | Antibacterial compositions and their use | |
Weber et al. | Self-disinfecting surfaces | |
WO2003011821A2 (en) | Use of cyclic heptapeptides for the inhibition of biofilm formation | |
Oka et al. | Efficacy of titanium dioxide photocatalyst for inhibition of bacterial colonization on percutaneous implants | |
KR20130059421A (en) | Silver iodate compounds having antimicrobial properties | |
Manivasagam et al. | Enhanced antibacterial properties on superhydrophobic micro‐nano structured titanium surface | |
Didem et al. | Evaluation of antimicrobial durability and anti-biofilm effects in urinary catheters against Enterococcus faecalis clinical isolates and reference strains | |
Si et al. | A heterogeneous TiO2/SrTiO3 coating on titanium alloy with excellent photocatalytic antibacterial, osteogenesis and tribocorrosion properties | |
Koseki et al. | Clinical and histomorphometrical study on titanium dioxide-coated external fixation pins | |
Cooper et al. | The potential of photo-deposited silver coatings on Foley catheters to prevent urinary tract infections | |
Francolini et al. | Biofilms, biomaterials, and device-related infections | |
US9586381B1 (en) | Metal plated object with biocidal properties | |
WO2019008950A1 (en) | Method for treating surface of copper or copper alloy, surface treatment liquid for sterilizing copper or copper alloy, and sterilizing method using copper or copper alloy treated using said method | |
Mohammed et al. | Bacterial biofilm: a major challenge of catheterization | |
EP2229962A1 (en) | Medical-surgical devices with antibacterial coating for human or animal implant and a method for their production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ELECTRO-SPEC, INC., INDIANA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SMITH, JEFFREY D.;REEL/FRAME:034684/0927 Effective date: 20150109 Owner name: STERIPLATE, LLC, INDIANA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ELECTRO-SPEC, INC.;REEL/FRAME:034685/0398 Effective date: 20150109 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2551); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Year of fee payment: 4 |